The US Food and Drug Administration approved remdesivir for the treatment of coronavirus infection, the drug’s maker, Gilead Sciences, said Thursday.
The US Food and Drug Administration approved remdesivir for the treatment of coronavirus infection, the drug’s maker, Gilead Sciences, said Thursday.
